论文部分内容阅读
目的 :本次对乳糖酸阿奇霉素治疗小儿支气管肺炎临床效果进行观察。方法 :选取在我院接受治疗的支气管肺炎患儿80例作为本次研究对象,分为对照组和实验组各40例,对照组患儿给予头孢拉定治疗,实验组患儿给予乳糖酸阿奇霉素治疗,一周后对比两组患儿治疗效果。结果:通过一周治疗后,实验组的显效22例,有效19例,无效1例,总有效率97.5%,对照组的显效15例,有效21例,无效4例,总有效率90.0%,通过对两组患者的效果比较,实验组的总有效率明显要比对照组高,两组患者的比较差异比较具有统计学意义(p<0.05)。结论:对小儿支气管肺炎的治疗,主要采用乳糖酸阿奇霉素治疗,可以有效的降低患者的头痛、发热、气促、咳嗽以及呼吸困难等现象,在临床中取得了显著的效果,值得临床推广使用。
Objective: The clinical observation of azithromycin lactobionate treatment of bronchial pneumonia in children was observed. Methods: Totally 80 children with bronchopneumonia treated in our hospital were selected as the object of this study and divided into control group and experimental group of 40 cases each. The control group was given cefradine treatment. The experimental group was given azithromycin lactobionate, One week later, the therapeutic effects of two groups of children were compared. Results: After a week of treatment, the experimental group markedly effective in 22 cases, effective in 19 cases, ineffective in 1 case, the total effective rate was 97.5%, the control group markedly effective in 15 cases, effective in 21 cases, ineffective in 4 cases, the total effective rate of 90.0% Compared with the control group, the total effective rate in the experimental group was significantly higher than that in the control group. The difference between the two groups was statistically significant (p <0.05). Conclusion: The treatment of pediatric bronchopneumonia is mainly treated with azithromycin lactobionate, which can effectively reduce the symptoms of headache, fever, shortness of breath, cough and dyspnea in the patients and has achieved remarkable results in clinic and is worthy of clinical promotion.